drugset / Trial / NCT03558555

Determine the Clinical Advantage of IV vs PO Acetaminophen

NCT03558555 ↗

Phase 4 Completed 103 enrolled Yan Lai
RandomizedParallel-groupQuadruple-blindTreatment

Summary

There is limited research on the clinical outcome differences between intravenous (IV) acetaminophen versus oral (PO) acetaminophen. With the costs of intravenous acetaminophen sometimes being almost 100 times the cost of PO acetaminophen, it is not only important fiscally but also clinically to differentiate the benefits of IV vs PO acetaminophen. The proposed research study is to determine the clinical advantages of IV vs PO acetaminophen during the post-operative recovery time for ambulatory surgery patients by analyzing differences in time to first opioid delivery, pain scores, and patient satisfaction.

Timeline

Start
2017-12-08
Primary completion
2018-12-30
Completion
2018-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 975 mg Intravenous
Comparator Acetaminophen Small molecule 1000 mg Intravenous

Indications

No indication recorded.